MedPath

â??Clinical trial of Siddha drugs Parangipattai Kudineer (Internally) and Sivappu Thylam (Externally) in the treatment of Kalanjaga Padai (Psoriasis) with and without Yogam therapyâ??

Phase 2
Conditions
Health Condition 1: null- Patients with symptoms of dry erythematous macules with silvery scales without any structural changes in any part of the bodyHealth Condition 2: L409- Psoriasis, unspecifiedHealth Condition 3: L409- Psoriasis, unspecified
Registration Number
CTRI/2018/07/015115
Lead Sponsor
Dr K Archana
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)History of Non Insulin Dependent Diabetes Mellitus

2)Dry erythematous macules with silvery scaly lesion without any structural changes in any part of the body.

3) Itching

4)Erythema

5)Scaling

6)Auspitz sign +

7)Candle crease sign +

8)Willing to give specimen of blood for the investigation whenever required.

9)Willing to take photograph

10)Willing to participate in trial and signing consent by fulfilling the condition of Proforma.

Exclusion Criteria

1.History of Insulin Dependent Diabetes Mellitus

2.Pregnancy and lactation

3.History of Psoriasis with evidence of any other skin disease or Evidences of secondary infection in the lesions.

4.History of Psoriatic arthropathy

5.History of Cardiac diseases

6.History of Hansenâ??s disease

7.History of any other chronic illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath